Here, in this study, samples from CNS-GBM and CNS-Oligo were combined to obtain a greater number of IDH1 mutants from both gliomas that have been relatively well studied for the IDH1 mutation-associated oncometabolites [19, 20]. Here, IDH1 is linked to central nervous system cancer.